SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001387131-13-004247
Filing Date
2013-11-14
Accepted
2013-11-13 18:47:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT admp-424b3_111313.htm 424B3 503045
2 SUBLEASE ex10-3.htm EX-10.3 108192
3 admp-logo.jpg GRAPHIC 9379
4 q1301854001_v1.jpg GRAPHIC 6806
5 q1301854002_v1.jpg GRAPHIC 27204
6 q1301854003_v1.jpg GRAPHIC 68858
7 q1301854004_v1.jpg GRAPHIC 5726
8 q1301854005_v1.jpg GRAPHIC 2096
9 q1301854006_v1.jpg GRAPHIC 2213
10 q1301854007_v1.jpg GRAPHIC 2238
11 q1301854008_v1.jpg GRAPHIC 2213
  Complete submission text file 0001387131-13-004247.txt   788113
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 424B3 | Act: 33 | File No.: 333-190798 | Film No.: 131216104
SIC: 2834 Pharmaceutical Preparations